// App-Quantinova.ai

: RELATIONSHIP BETWEEN 24-HOUR AMBULATORY BRACHIAL VERSUS AORTIC SYSTOLIC BLOOD PRESSURE AND LEFT VENTRICULAR MASS. THE INTERNATIONAL 24 HOUR AORTIC BLOOD PRESSURE CONSORTIUM

Researchers

Presenter

  • Weber, T

Principal Investigators

  • Protogerou, A

  • Sharman, J

  • Sala, E. Rodilla

  • Jankowski, P

  • Muiesan, M.L

  • Giannattasio, C

  • Wilkinson, I

  • Hametner, B

  • Pascual, J.M

  • Zweiker, R

  • Czarnecka, D

  • Argyris, A

  • Paini, A

  • Salvetti, M

  • Maloberti, A

  • Mceniery, C

  • Li, Y

  • Nemcsik, J

  • Pucci, G

Medical Centers

  • Center for Health & Bioresources, Biomedical systems, Austrian Institute of Technology, Vienna, Austria

  • Cardiovascular Prevention & Research Unit, Department of Pathophysiology, Medical School, Laiko Hospital, National and K, Athens, Greece

  • Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Tasmania, Australia

  • Department of Medicina Interna, Hospital de Sagunto, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain

  • st Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University, Medical College, University Hospital, Kracow, Poland

  • Department of Clinical and Experimental Sciences. University of Brescia, Brescia, Italy

  • Cardiology IV, ’A. De Gasperis’ Department, ASTT Ospedale Niguarda Ca’ Granda, School of Medicine and Surgery Department, Milan, Italy

  • Ragada, Division of Experimental Medicine and Immunotherapeutics, Cambridge, United Kingdom

  • Cardiology Department, Medical University Graz, Graz, AUSTRIA

  • Shanghai Cancer Institute, Shanghai Jiaotong University School of Medicine, Shanghai, China

  • Semmelweis University, Budapest, Hungary

  • Unit of Internal Medicine, Terni University Hospital, Department of Medicine, University of Perugia, Italy

  • Cardiology Department, Klinikum Wels-Grieskirchen, Vienna, Austria

Locations

  • Austria

  • Greece

  • Australia

  • Spain

  • Poland

  • Italy

  • United Kingdom

  • China

  • Hungary

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Fibrillin-1

  • Sex hormone binding globulin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved